|
Volumn 65, Issue 5, 2008, Pages 403-413
|
Paliperidone for schizophrenia
|
Author keywords
Antipsychotic agents; Dosage; Drug administration; Drug interactions; Mechanism of action; Paliperidone; Pharmacokinetics; Schizophrenia; Sustained action medications; Toxicity
|
Indexed keywords
CHLORPROMAZINE;
CLOZAPINE;
FLUPHENAZINE;
HALOPERIDOL;
OLANZAPINE;
PALIPERIDONE;
PLACEBO;
QUETIAPINE;
RISPERIDONE;
ZIPRASIDONE;
9 HYDROXY RISPERIDONE;
9-HYDROXY-RISPERIDONE;
ISOXAZOLE DERIVATIVE;
NEUROLEPTIC AGENT;
PYRIMIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
AGITATION;
ANXIETY;
BINDING AFFINITY;
CLINICAL TRIAL;
DIZZINESS;
DRUG ABSORPTION;
DRUG DEGRADATION;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG EXCRETION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSPEPSIA;
ENZYME METABOLISM;
HEADACHE;
HUMAN;
HYPERKINESIA;
INSOMNIA;
PRIORITY JOURNAL;
PSYCHOSIS;
REVIEW;
SCHIZOPHRENIA;
SIDE EFFECT;
SOMNOLENCE;
TACHYCARDIA;
TREATMENT OUTCOME;
TREMOR;
UNITED STATES;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DELAYED RELEASE FORMULATION;
DRUG INTERACTION;
METABOLISM;
ANTIPSYCHOTIC AGENTS;
CONTROLLED CLINICAL TRIALS AS TOPIC;
DELAYED-ACTION PREPARATIONS;
DRUG INTERACTIONS;
HUMANS;
ISOXAZOLES;
PYRIMIDINES;
RISPERIDONE;
SCHIZOPHRENIA;
|
EID: 40349102037
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/ajhp070261 Document Type: Review |
Times cited : (54)
|
References (54)
|